Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    M. Alexander Otto

    M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.

    News

    IV fluid weaning unnecessary after gastroenteritis rehydration

    Author:
    M. Alexander Otto
    Publish date: August 6, 2019

    SEATTLE – Saving “even a couple hours” to get kids out of the hospital quicker matters.

    • Read More

    News

    Too many blood cultures ordered for pediatric SSTIs

    Author:
    M. Alexander Otto
    Publish date: August 2, 2019

    SEATTLE – Culture draws were associated with a 20% increase in hospital length of stay.

    • Read More

    News

    Enteral feeding is safe during bronchiolitis HFNC

    Author:
    M. Alexander Otto
    Publish date: August 2, 2019

    SEATTLE – Parents feel better when they know their children are “getting food in their belly.”

    • Read More

    News

    Short-course azithromycin no benefit in pediatric asthma admissions

    Author:
    M. Alexander Otto
    Publish date: July 31, 2019

    SEATTLE – Clinicians should consider these data before prescribing azithromycin to children hospitalized with asthma.

    • Read More

    News

    DECLARE-TIMI58 shows improved kidney function with dapagliflozin

    Author:
    M. Alexander Otto
    Publish date: July 22, 2019

    SAN FRANCISCO – The SGLT2 dapagliflozin was better than placebo at slowing down kidney disease in patients with type 2 diabetes

    • Read More

    News

    CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes

    Author:
    M. Alexander Otto
    Publish date: July 16, 2019

    SAN FRANCISCO – The study was unusual among other DPP-4 trials in that almost 60% of the patients were older than 65, and 62.3% had impaired renal...

    • Read More

    News

    BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults

    Author:
    M. Alexander Otto
    Publish date: July 12, 2019

    SAN FRANCISCO – One risk factor should trigger screening in normal weight.

    • Read More

    News

    Low-fat dairy associated with decreased risk of type 2 diabetes

    Author:
    M. Alexander Otto
    Publish date: July 11, 2019

    SAN FRANCISCO – An indicator of healthy living, or a true effect?

    • Read More

    News

    Type 2 diabetes is particularly devastating in adolescents

    Author:
    M. Alexander Otto
    Publish date: July 10, 2019

    SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....

    • Read More

    News

    Misguided fear is keeping benzodiazepines from elderly

    Author:
    M. Alexander Otto
    Publish date: July 9, 2019

    SAN FRANCISCO – Benzos are “wonderful” for geriatric anxiety and anxiety-related insomnia, said Dr. Carl Salzman of Harvard Medical School.

    • Read More

    News

    VOC-sniffing necklace may support early detection of hypoglycemia

    Author:
    M. Alexander Otto
    Publish date: July 2, 2019

    SAN FRANCISCO – Same trick as diabetes alert dogs – minus the pup.

    • Read More

    News

    CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma

    Author:
    M. Alexander Otto
    Publish date: July 1, 2019

    SAN FRANCISCO – Concerns remain around glimepiride-related weight gain and hypoglycemia.

    • Read More

    News

    Ketamine edges out ECT for refractory depression in small study

    Author:
    M. Alexander Otto
    Publish date: June 29, 2019

    ECT maybe more durable than ketamine as a treatment.

    • Read More

    News

    Daratumumab wins new indication for newly diagnosed myeloma patients

    Author:
    M. Alexander Otto
    Publish date: June 28, 2019

    Daratumumab plus lenalidomide and dexamethasone (DRd) is now approved for newly diagnosed myeloma patients who are ineligible for autologous stem...

    • Read More

    News

    Medical cannabis legalization outpacing evidence

    Author:
    M. Alexander Otto
    Publish date: June 25, 2019

    SAN FRANCISCO – Sparse evidence on cannabis is based on observational studies – not RCTs, said Dr. Kevin P. Hill.

    • Read More

    Pages

    • « first
    • …
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery